BBO-8520

· BridgeBio Oncology Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BBO-8520, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer [Phase 1]